Merck Animal Health, a division of Merck, announced the expansion of the newly USDA-approved Nobivac NXT vaccine platform to include a best-in-class solution to protect cats against one of the most common feline infectious diseases, feline leukemia virus, or FeLV. The vaccine is expected to be available at veterinary clinics and hospitals nationwide this fall.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Morning Movers: Apellis slips following negative CHMP opinion
- Merck announces CHMP recommendation for two Keytruda indications
- Zoetis price target raised to $210 from $200 at Stifel
- Merck’s KEYTRUDA receives FDA approval for treatment of MPM
- FDA approves Keytruda+pemetrexed in malignant pleural mesothelioma